The latest immunotherapy news and developments
Microbiome mastery: Enhancing cancer care
The microbiome could be the key to identifying individuals who can benefit from combination immunotherapy…
Browsing: Immunotherapy
Immunotherapy combination may benefit patients with transplanted kidneys and advanced skin cancers
People who have had a kidney transplant are at high risk for developing skin cancers.…
Immune cell receptor provides promising immunotherapy target
Drugs that target a receptor on immune cells called activin receptor 1C may combat tumour-induced…
Biomarker-directed combination effective in immunotherapy-resistant lung cancer
A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune…
Soft-tissue sarcoma: neoadjuvant immunotherapy improves long-term survival
Patients with soft-tissue sarcoma treated with neoadjuvant, or pre-surgical, immunotherapy had very little residual tumour at the time of…
Promising target for CAR T-cell therapy for cutaneous and rare melanomas
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center, USA, have built and demonstrated the…
T cells made 100 times more potent at targeting cancer cells
Scientists at the UC San Francisco (UCSF) and Northwestern Medicine, USA, may have found a…
Immune networks in tumours prime responses to a personalised immunotherapy
Through an analysis of tumour samples collected over time from patients with advanced melanoma, a…
Immunotherapy post-surgery improves overall survival for kidney cancer
For the first time in fifty years, results from a phase 3 randomised, placebo-controlled trial…
ASCO GI 2024: Dual immunotherapy treatment improves progression-free survival in certain patients with advanced colorectal cancer
The dual immunotherapy combination of nivolumab and ipilimumab reduced the risk of disease progression or…